1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with lovastatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Aoki, Y; Arisawa, M; Kato, H; Katsume, A; Kohara, M; Ohta, A; Okamoto, K; Sakamoto, H; Shimma, N; Sudoh, M; Tsukuda, T | 1 |
1 other study(ies) available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and lovastatin
| Article | Year |
|---|---|
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
Topics: Cell Line; Citrates; Hepacivirus; Hepatitis C; Humans; Membrane Microdomains; Phenylpropionates; Protein Binding; Protein Conformation; Sphingolipids; Viral Nonstructural Proteins; Virus Replication | 2005 |